AzTrials
AzTrials

Intensive CareMATNCT06628440

Development and Validation of a Mouth Assessment Tool for Orally Intubated Patients in Intensive Care Unit)

An observational study of Intensive Care, run by University Hospital, Bordeaux at 10 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Oro-tracheal Intubation uses oro-pharyngeal lesions, impacting on the length and quality of the patient's hospital stay. There are no oral status assessment tools specifically adapted to orally intubated patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intensive Care
What is being tested?
oral condition assessment tool
Type of treatment
Pill or oral medicine
How many people
500 participants
Where
10 sitesFrance
Study dates
31 Mar 2026to Oct 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patient hospitalized in an adult intensive care undergoing oro-tracheal intubation.

Who may be able to join

  • Person aged 18 or over
  • Person hospitalized in an adult intensive care unit for medical, surgical, polyvalent or burns specialties.
  • Person undergoing oro-tracheal intubation.
  • Person affiliated with or benefiting from a social security scheme.
  • Free and informed oral consent of the patient or his/her legal representative

Who cannot join

  • Person undergoing Limitation or Cessation of Active Therapeutics
  • Person wearing a multi-attachment fixed dental appliance (braces, multi-rings, brackets bonded to teeth)
  • Person with oral damage making it impossible to measure one of the items on the oral cavity assessment tool (e.g.: removal of the tongue, etc.).
  • Patient under protective supervision (safeguard of justice, curatorship, guardianship)
  • Refusal of patient or legal representative to participate

Trial locations and contacts

10 sites in 1 country. Contact the study team or a site near you to ask about taking part.

10 sites in 1 country

France10 sites, 10 recruiting
  • CHU Angers

    Angers

    Carole HAUBERTIN, Carole.haubertin@chu-angers.fr

    Not yet recruiting
  • CHU de Bordeaux - Aile 1 Tripode

    Bordeaux

    Pierre GODARD, Dr, pierre.godard.ext@chu-bordeaux.fr

    Not yet recruiting
  • CHU de Bordeaux - Aile 2 Tripode

    Bordeaux

    Vivien GUILLOTIN, Dr, vivien.guillotin@chu-bordeaux.fr

    Not yet recruiting
  • CHU de Bordeaux - Pellegrin

    Bordeaux

    Hugues De Courson, Dr, hugues.de-courson@chu-bordeaux.fr

    Recruiting
  • CHU de Bordeaux - Saint André

    Bordeaux

    Renaud Prevel, Dr, renaud.prevel@chu-bordeaux.fr

    Not yet recruiting
  • CHU Caen

    Caen

    Agathe HAMELIN, Dr, Hamelin-a@chu-caen.fr

    Not yet recruiting
  • CH Libourne

    Libourne

    Hubert GRAND, Dr, Hubert.grand@ch-libourne.fr

    Not yet recruiting
  • CHU de Bordeaux - Haut Levêque

    Pessac

    Antoine BEURTON, Dr, antoine.beurton@chu-bordeaux.fr

    Not yet recruiting
  • Hôpital d'Instruction des Armées Sainte Anne

    Toulon

    Fanny GIANNONI, Fanny.giannoni@intradef.gouv.fr

    Not yet recruiting
  • Hôpitaux Nord Franche comté

    Trévenans

    Valérie CHAUVIN, Dr, Valerie.chauvin@hnfc.fr

    Not yet recruiting

Other trials in France

About this study

Oro-tracheal Intubation uses oro-pharyngeal lesions, impacting on the length and quality of the patient's hospital stay.

There are no oral status assessment tools specifically adapted to orally intubated patients.

It is therefore necessary to create a new tool for assessing the condition of the oral cavity, specific to oro-intubated patients in intensive care.

The aim of the protocol is to evaluate the metrological performance of the newly-developed tool for assessing the state of the oral cavity in adult orally intubated intensive care patients.

Read the detailed description

In France, according to the "medicalized information system program" national database, 230,000 adults are admitted to the intensive care unit every year, 40% of them undergoing invasive mechanical ventilation. That's 90,000 patients for whom an Oro-Tracheal Intubation (OTI) tube is inserted through the mouth into the trachea.

OTI causes oro-pharyngeal lesions, impacting on the length and quality of the patient's hospital stay.

As early as 48 hours after admission to intensive care, the patient's oral and dental condition deteriorates. Pressure lesions can occur, with the OTI probe responsible for 22% to 26% of pressure sores related to invasive equipment. Anarchic chewing also causes injuries to lips, tongue, gums, mucosa and teeth.

In time, these injuries can lead to swallowing disorders, a mechanism for feeding and protecting the airways, and impair the patient's quality of life.

Caregivers in intensive care units have developed mouth care protocols to maintain hygiene and comfort, and prevent lesions that can spread from the lips to the trachea during OTI.

Many mouth care protocols exist, but there is no "gold standard". Certain practices are encouraged as part of the prevention of Ventilator-Acquired Pneumonia (VAP) (mainly tooth brushing). Mouth care practices in France remain highly heterogeneous. In order to improve practices, it is essential not only to have best practice guidelines for preventing and treating lesions, but also to have appropriate and valid tools for assessing the oral condition of intubated patients. Good assessment is a prerequisite for good treatment/care.

To investigators knowledge, there are no oral status assessment tools specifically adapted to intubated patients.

Tools do exist for populations at risk due to age or chemotherapy, but these have often been created without multidisciplinary advice, validated in a population without OTI, and do not allow for an assessment of the state of the oral cavity appropriate to the problems of intubated patients.

It is therefore necessary to create a new tool for assessing the condition of the oral cavity, specific to oro-intubated patients in intensive care, by bringing together experts in intensive care, oral health, hygiene, wound healing and patient partners, and to validate it in this patient population. The tool must also be relevant to the fields of competence of nurses, for use in daily practice.

The aim of the protocol is to evaluate the metrological performance of the newly-developed tool for assessing the state of the oral cavity in adult oro-intubated intensive care patients.

Conditions
Intensive Care
Being tested
oral condition assessment tool
Keywords
intensive care, oral care, paramedical care, oro-tracheal intubation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • oral condition assessment toolOther

    Use of the Mat assessment tool by a nurse on the participant

Study groups in NCT06628440
Study groupRoleWhat they receive
Patientsintensive care patient with oro-tracheal intubation
Receives: Other: oral condition assessment tool

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Metrological performance of the Mouth Assessment Tool (MAT)

    The general evaluation criterion is the tool's metrological performance according to COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) psychometric criteria.

    Measured: At inclusion (Day 0)

Secondary outcomes (3)
  1. Content validity of the Mouth Assessment Tool (MAT)

    Relevance of items, completeness of key concepts, understanding of items by target population

    Measured: At inclusion (Day 0)

  2. Construct validity of the Mouth Assessment Tool (MAT)

    Structural validity of the dimensional tool Hypothesis testing Measurement invariance in different population subgroups

    Measured: At inclusion (Day 0)

  3. Reliability of the Mouth Assessment Tool (MAT)

    Reproducibility Internal consistency

    Measured: At inclusion (Day 0)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2024
  2. Study start31 Mar 2026
  3. Primary completionOct 2028 (estimated)
  4. Study completionOct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06628440
Sponsor's protocol ID
CHUBX 2023/48
Acronym
MAT
Status last verified
Apr 2026
First submitted
27 Aug 2024
Last updated
7 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Intensive Care, run by University Hospital, Bordeaux at 10 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 10 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Oriane BOUISSIERE (0556795361 ext. 33, oriane.bouissiere@chu-bordeaux.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Metrological performance of the Mouth Assessment Tool (MAT) (time frame: At inclusion (Day 0)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in